We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.63%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$82.8B
AUM Growth
+$1.44B
(+1.8%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-2.43%
Top 10 Holdings %
Top 10 Hldgs %
16.17%
Holding
1,933
New
90
Increased
882
Reduced
857
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$366M |
| 2 |
CarMax
KMX
|
+$273M |
| 3 |
O'Reilly Automotive
ORLY
|
+$240M |
| 4 |
Motorola Solutions
MSI
|
+$212M |
| 5 |
Alibaba
BABA
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nektar Therapeutics
NKTR
|
+$401M |
| 2 |
TechnipFMC
FTI
|
+$399M |
| 3 |
AutoZone
AZO
|
+$327M |
| 4 |
Cisco
CSCO
|
+$232M |
| 5 |
NetEase
NTES
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.41% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Energy | 13.48% |
| 4 | Healthcare | 12.91% |
| 5 | Technology | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RMP
126
DELISTED
Rice Midstream Partners LP
RMP
| $173M | 0.21% |
8,037,144
-1,171,543
| -13% | -$24.5M |
|
|
BLUE
127
DELISTED
bluebird bio
BLUE
| $171M | 0.21% |
74,242
-500
| -0.7% | -$1.02M |
|
|
NBIS
128
Nebius Group N.V.
NBIS
$47.7B
| $167M | 0.2% |
+5,110,710
| New | +$167M |
|
|
SMC
129
Summit Midstream
SMC
$421M
| $167M | 0.2% |
542,220
-16,295
| -3% | -$4.93M |
|
130
Williams Companies
WMB
$90.5B
| $167M | 0.2% |
5,461,721
+316,278
| +6% | +$9.2M |
|
131
Fidelity National Financial
FNF
$13.9B
| $166M | 0.2% |
4,398,579
-1,733,253
| -28% | -$63.2M |
|
|
CERN
132
DELISTED
Cerner Corp
CERN
| $165M | 0.2% |
2,453,167
-195,143
| -7% | -$13.5M |
|
|
ENLK
133
DELISTED
EnLink Midstream Partners, LP
ENLK
| $165M | 0.2% |
10,711,329
-1,448,109
| -12% | -$22.7M |
|
134
XPO
XPO
$25B
| $164M | 0.2% |
5,182,023
+117,035
| +2% | +$2.99M |
|
|
WES
135
DELISTED
Western Gas Partners Lp
WES
| $164M | 0.2% |
3,405,766
-484,434
| -12% | -$23M |
|
136
Newell Brands
NWL
$2.16B
| $161M | 0.19% |
5,210,352
+3,537,489
| +211% | +$122M |
|
137
Centene
CNC
$31.3B
| $159M | 0.19% |
3,156,388
+516
| +0% | +$25K |
|
138
Republic Services
RSG
$66.7B
| $158M | 0.19% |
2,335,645
+1,081,097
| +86% | +$69.7M |
|
|
DFS
139
DELISTED
Discover Financial Services
DFS
| $154M | 0.19% |
2,005,436
-435,100
| -18% | -$29.9M |
|
|
EXAS
140
DELISTED
Exact Sciences
EXAS
| $153M | 0.19% |
2,920,841
-114,244
| -4% | -$6.1M |
|
|
TEP
141
DELISTED
Tallgrass Energy Partners, LP
TEP
| $153M | 0.18% |
3,326,302
-270,266
| -8% | -$12.3M |
|
142
PTC
PTC
$13.7B
| $148M | 0.18% |
2,437,662
+21,955
| +0.9% | +$1.36M |
|
143
Cedar Fair
FUN
$1.78B
| $148M | 0.18% |
2,276,115
+245,795
| +12% | +$16.1M |
|
|
CEQP
144
DELISTED
Crestwood Equity Partners LP
CEQP
| $146M | 0.18% |
5,658,999
+57,400
| +1% | +$1.4M |
|
145
Acadia Pharmaceuticals
ACAD
$4.25B
| $145M | 0.18% |
4,813,099
-325,374
| -6% | -$10.4M |
|
146
Antero Midstream
AM
$10.8B
| $145M | 0.17% |
7,345,428
+1,293,282
| +21% | +$24M |
|
147
Wabtec
WAB
$51.1B
| $144M | 0.17% |
1,765,784
+259,671
| +17% | +$19.9M |
|
148
Ventas
VTR
$48.9B
| $139M | 0.17% |
2,312,111
+44,247
| +2% | +$2.8M |
|
149
Compass Minerals
CMP
$1.24B
| $138M | 0.17% |
1,912,663
+425,753
| +29% | +$28.7M |
|
150
Starbucks
SBUX
$118B
| $138M | 0.17% |
2,399,124
+401,839
| +20% | +$22.7M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q4 2017 Portfolio in Review
As of Q4 2017, OppenheimerFunds held 1,933 positions worth $82.8B, up 1.8% from $81.4B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q4 2017 filing shows 90 new, 882 increased, 857 reduced and 96 closed positions. Its largest new stake was Nebius Group N.V.: 5,110,710 shares worth $167M. The largest sale was Nektar Therapeutics, an estimated $401M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Energy.
- OppenheimerFunds's largest Q4 2017 buy was Nebius Group N.V.: 5,110,710 shares worth $167M.
- OppenheimerFunds added most to eBay in Q4 2017, an estimated $366M increase.
- OppenheimerFunds's biggest Q4 2017 reduction was Nektar Therapeutics, cutting an estimated $401M.
- OppenheimerFunds fully exited NetEase in Q4 2017, selling an estimated $181M.
- OppenheimerFunds's ten largest holdings make up 16% of its $82.8B portfolio in Q4 2017.
- OppenheimerFunds opened 90 new positions and closed 96 in Q4 2017.
- OppenheimerFunds's portfolio value rose 1.8% quarter-over-quarter to $82.8B.
Based on OppenheimerFunds's 13F filing for Q4 2017, filed 12 Feb 2018.